Second-line antiretroviral therapy: Long-term outcomes in South Africa

Simple item page
dc.contributor.authorMurphy RA
dc.contributor.authorSunpath H
dc.contributor.authorCastilla C
dc.contributor.authorEbrahim S
dc.contributor.authorCourt R
dc.contributor.authorNguyen H
dc.contributor.authorKuritzkes DR
dc.contributor.authorMarconi VC
dc.contributor.authorNachega JB
dc.date.accessioned2013-07-03T08:19:00Z
dc.date.available2013-07-03T08:19:00Z
dc.date.issued2012
dc.descriptionGeneeskunde en Gesondheidswetenskappe
dc.descriptionInterne Geneeskunde
dc.descriptionPlease help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za
dc.identifier.citationJAIDS-Journal of Acquired Immune Deficiency Syndromes
dc.identifier.urihttp://hdl.handle.net/10019.1/81637
dc.publisherLIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA,19106-3621
dc.titleSecond-line antiretroviral therapy: Long-term outcomes in South Africa
dc.typeJournal Articles (subsidised)
Files
Collections
2012 - Research Outputs